Loading…
Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent
Saved in:
| Published in: | Journal of medicinal chemistry 2012-04, Vol.55 (8), p.4025-4025 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 4025 |
| container_issue | 8 |
| container_start_page | 4025 |
| container_title | Journal of medicinal chemistry |
| container_volume | 55 |
| creator | Hudkins, Robert L Becknell, Nadine C Zulli, Allison L Underiner, Ted L Angeles, Thelma S Aimone, Lisa D Albom, Mark S Chang, Hong Miknyoczki, Sheila J Hunter, Kathryn Jones-Bolin, Susan Zhao, Hugh Bacon, Edward R Mallamo, John P Ator, Mark A Ruggeri, Bruce A |
| description | |
| doi_str_mv | 10.1021/jm300413f |
| format | article |
| fullrecord | <record><control><sourceid>acs</sourceid><recordid>TN_cdi_acs_journals_10_1021_jm300413f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>b680153769</sourcerecordid><originalsourceid>FETCH-LOGICAL-a65f-cf62b8dc6e0b4185f7b90a4a0694e6091f4ccfcf75192b5fb916c4735fa5ee0d3</originalsourceid><addsrcrecordid>eNpdUk2P0zAQDQgkysKBf-ALUivtUNtx0oZbKemHKOxqqfaCVpXj2I27jh05CUv49bi7iAOnmXnvad6M9KLoHcEfCKZkeqpjjBmJ1fNoRBKKgc0xexGNMKYUaErjV9Hrtj1hjGNC49GzX0vnvRSddhZ1Dn0fbFfJVreI2xJ90s64oxbcoGvvlDYSOYWCADXcwi1vRW-4R7ktXQCNDrq1dw9dhVZcdM6jGylkE5rpfvCu1VaiL9ryVqIHHUTbuu6tOxpX9EbbR8e80aX09f-LYKfvJdq4-nzPgD67mmvbIorGt_l6BTfT_TYHOkFbW-lCn50JgTGFr7KrBtN41wxmAoRekhhKXQ2ld0ChfmRhDuNm8LrWpbYBHQyvtXUTYBvQtuS_g-eP5JIBvwsyf57iMIk7wX1xZoGBC5-Nl_k1EJLNyeQjWqBv7qc06MqKp5P3lfS8kX2nBVocpe3eRC8VN618-7deRPtVvl9uYHe13i4XO-BpokColBbzUqQSF4zMEzUrMswZx2nGZIozopgQSqhZQjJaJKrISCrYLE4UT6TEZXwRvX9ay0V7OLne22B2IPhwTsvhX1riP-qxtTA</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Hudkins, Robert L ; Becknell, Nadine C ; Zulli, Allison L ; Underiner, Ted L ; Angeles, Thelma S ; Aimone, Lisa D ; Albom, Mark S ; Chang, Hong ; Miknyoczki, Sheila J ; Hunter, Kathryn ; Jones-Bolin, Susan ; Zhao, Hugh ; Bacon, Edward R ; Mallamo, John P ; Ator, Mark A ; Ruggeri, Bruce A</creator><creatorcontrib>Hudkins, Robert L ; Becknell, Nadine C ; Zulli, Allison L ; Underiner, Ted L ; Angeles, Thelma S ; Aimone, Lisa D ; Albom, Mark S ; Chang, Hong ; Miknyoczki, Sheila J ; Hunter, Kathryn ; Jones-Bolin, Susan ; Zhao, Hugh ; Bacon, Edward R ; Mallamo, John P ; Ator, Mark A ; Ruggeri, Bruce A</creatorcontrib><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm300413f</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2012-04, Vol.55 (8), p.4025-4025</ispartof><rights>Copyright © 2012 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hudkins, Robert L</creatorcontrib><creatorcontrib>Becknell, Nadine C</creatorcontrib><creatorcontrib>Zulli, Allison L</creatorcontrib><creatorcontrib>Underiner, Ted L</creatorcontrib><creatorcontrib>Angeles, Thelma S</creatorcontrib><creatorcontrib>Aimone, Lisa D</creatorcontrib><creatorcontrib>Albom, Mark S</creatorcontrib><creatorcontrib>Chang, Hong</creatorcontrib><creatorcontrib>Miknyoczki, Sheila J</creatorcontrib><creatorcontrib>Hunter, Kathryn</creatorcontrib><creatorcontrib>Jones-Bolin, Susan</creatorcontrib><creatorcontrib>Zhao, Hugh</creatorcontrib><creatorcontrib>Bacon, Edward R</creatorcontrib><creatorcontrib>Mallamo, John P</creatorcontrib><creatorcontrib>Ator, Mark A</creatorcontrib><creatorcontrib>Ruggeri, Bruce A</creatorcontrib><title>Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpdUk2P0zAQDQgkysKBf-ALUivtUNtx0oZbKemHKOxqqfaCVpXj2I27jh05CUv49bi7iAOnmXnvad6M9KLoHcEfCKZkeqpjjBmJ1fNoRBKKgc0xexGNMKYUaErjV9Hrtj1hjGNC49GzX0vnvRSddhZ1Dn0fbFfJVreI2xJ90s64oxbcoGvvlDYSOYWCADXcwi1vRW-4R7ktXQCNDrq1dw9dhVZcdM6jGylkE5rpfvCu1VaiL9ryVqIHHUTbuu6tOxpX9EbbR8e80aX09f-LYKfvJdq4-nzPgD67mmvbIorGt_l6BTfT_TYHOkFbW-lCn50JgTGFr7KrBtN41wxmAoRekhhKXQ2ld0ChfmRhDuNm8LrWpbYBHQyvtXUTYBvQtuS_g-eP5JIBvwsyf57iMIk7wX1xZoGBC5-Nl_k1EJLNyeQjWqBv7qc06MqKp5P3lfS8kX2nBVocpe3eRC8VN618-7deRPtVvl9uYHe13i4XO-BpokColBbzUqQSF4zMEzUrMswZx2nGZIozopgQSqhZQjJaJKrISCrYLE4UT6TEZXwRvX9ay0V7OLne22B2IPhwTsvhX1riP-qxtTA</recordid><startdate>20120426</startdate><enddate>20120426</enddate><creator>Hudkins, Robert L</creator><creator>Becknell, Nadine C</creator><creator>Zulli, Allison L</creator><creator>Underiner, Ted L</creator><creator>Angeles, Thelma S</creator><creator>Aimone, Lisa D</creator><creator>Albom, Mark S</creator><creator>Chang, Hong</creator><creator>Miknyoczki, Sheila J</creator><creator>Hunter, Kathryn</creator><creator>Jones-Bolin, Susan</creator><creator>Zhao, Hugh</creator><creator>Bacon, Edward R</creator><creator>Mallamo, John P</creator><creator>Ator, Mark A</creator><creator>Ruggeri, Bruce A</creator><general>American Chemical Society</general><scope/></search><sort><creationdate>20120426</creationdate><title>Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent</title><author>Hudkins, Robert L ; Becknell, Nadine C ; Zulli, Allison L ; Underiner, Ted L ; Angeles, Thelma S ; Aimone, Lisa D ; Albom, Mark S ; Chang, Hong ; Miknyoczki, Sheila J ; Hunter, Kathryn ; Jones-Bolin, Susan ; Zhao, Hugh ; Bacon, Edward R ; Mallamo, John P ; Ator, Mark A ; Ruggeri, Bruce A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a65f-cf62b8dc6e0b4185f7b90a4a0694e6091f4ccfcf75192b5fb916c4735fa5ee0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hudkins, Robert L</creatorcontrib><creatorcontrib>Becknell, Nadine C</creatorcontrib><creatorcontrib>Zulli, Allison L</creatorcontrib><creatorcontrib>Underiner, Ted L</creatorcontrib><creatorcontrib>Angeles, Thelma S</creatorcontrib><creatorcontrib>Aimone, Lisa D</creatorcontrib><creatorcontrib>Albom, Mark S</creatorcontrib><creatorcontrib>Chang, Hong</creatorcontrib><creatorcontrib>Miknyoczki, Sheila J</creatorcontrib><creatorcontrib>Hunter, Kathryn</creatorcontrib><creatorcontrib>Jones-Bolin, Susan</creatorcontrib><creatorcontrib>Zhao, Hugh</creatorcontrib><creatorcontrib>Bacon, Edward R</creatorcontrib><creatorcontrib>Mallamo, John P</creatorcontrib><creatorcontrib>Ator, Mark A</creatorcontrib><creatorcontrib>Ruggeri, Bruce A</creatorcontrib><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hudkins, Robert L</au><au>Becknell, Nadine C</au><au>Zulli, Allison L</au><au>Underiner, Ted L</au><au>Angeles, Thelma S</au><au>Aimone, Lisa D</au><au>Albom, Mark S</au><au>Chang, Hong</au><au>Miknyoczki, Sheila J</au><au>Hunter, Kathryn</au><au>Jones-Bolin, Susan</au><au>Zhao, Hugh</au><au>Bacon, Edward R</au><au>Mallamo, John P</au><au>Ator, Mark A</au><au>Ruggeri, Bruce A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2012-04-26</date><risdate>2012</risdate><volume>55</volume><issue>8</issue><spage>4025</spage><epage>4025</epage><pages>4025-4025</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><pub>American Chemical Society</pub><doi>10.1021/jm300413f</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-2623 |
| ispartof | Journal of medicinal chemistry, 2012-04, Vol.55 (8), p.4025-4025 |
| issn | 0022-2623 1520-4804 |
| language | eng |
| recordid | cdi_acs_journals_10_1021_jm300413f |
| source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
| title | Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A48%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to%20Synthesis%20and%20Biological%20Profile%20of%20the%20pan-Vascular%20Endothelial%20Growth%20Factor%20Receptor/Tyrosine%20Kinase%20with%20Immunoglobulin%20and%20Epidermal%20Growth%20Factor-Like%20Homology%20Domains%202%20(VEGF-R/TIE-2)%20Inhibitor%2011-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo%5B5,4-a%5Dpyrrolo%5B3,4-c%5Dcarbazol-4-one%20(CEP-11981):%20A%20Novel%20Oncology%20Therapeutic%20Agent&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Hudkins,%20Robert%20L&rft.date=2012-04-26&rft.volume=55&rft.issue=8&rft.spage=4025&rft.epage=4025&rft.pages=4025-4025&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm300413f&rft_dat=%3Cacs%3Eb680153769%3C/acs%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a65f-cf62b8dc6e0b4185f7b90a4a0694e6091f4ccfcf75192b5fb916c4735fa5ee0d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |